Brawn Biotech Limited (BOM:530207)

India · Delayed Price · Currency is INR

22.34

+1.04 (4.88%)

At close: Aug 18, 2026

Brawn Biotech Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	173.07	169.78	134.75	164.95	222.36	86.21
Revenue Growth	13.87%	25.99%	-18.30%	-25.82%	157.93%	-75.35%
Gross Profit	25.6	24.59	13.83	19.73	29.11	17.33
Operating Income	-5.3	-4.48	-18.76	-15.63	-4.05	-20.57
Net Income	8.59	9.41	-17.4	-12.47	-8.68	-16.44
Earnings Per Share	2.90	3.26	-5.80	-4.16	-2.89	-5.48
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	119.74	155.28	206.74	79.54
Unallocated	14.91	9.67	15.57	6.67
Total	134.65	164.95	222.31	86.21

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	2.81	2.81	1.99	3.97	4.39	2.25
Total Debt	-	-	-	-	-	-
Net Cash (Debt)	2.81	2.81	1.99	3.97	4.39	2.25
Net Cash Growth	40.65%	40.68%	-49.80%	-9.46%	95.36%	-43.31%
Net Cash Per Share	0.95	0.97	0.66	1.32	1.46	0.75

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	1.12	0.47	-0.26	3.18	1.88
Capital Expenditures	-	-0.26	-2.42	-0.12	-0.96	-2.97
Free Cash Flow	-	0.86	-1.94	-0.38	2.22	-1.09
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	14.79%	14.48%	10.27%	11.96%	13.09%	20.10%
Operating Margin	-3.06%	-2.64%	-13.92%	-9.48%	-1.82%	-23.86%
Pretax Margin	-0.47%	0.01%	-13.34%	-9.36%	-1.85%	-24.57%
Profit Margin	4.96%	5.54%	-12.91%	-7.56%	-3.90%	-19.07%
FCF Margin	-	0.50%	-1.44%	-0.23%	1.00%	-1.27%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	7.35	6.65	-	-	-	-
P/FCF Ratio	74.64	73.06	-	-	22.33	-
PS Ratio	0.37	0.37	0.36	0.36	0.22	0.60